Pimobendan is a veterinary medication mainly used for the management of heart failure in dogs, especially conditions like myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). Pimobendan is classified as a calcium sensitizer and a selective inhibitor of phosphodiesterase 3 (PDE3). These properties give it both positive inotropic (increasing force of heart muscle contraction) and vasodilator (widening of blood vessels) effects. The additional benefit of vasodilation is a reduction in the heart’s workload and improved blood flow to the body. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pimobendane, Acardi and dl-Pimobendan. Its PubChem CID is 4823.
Pimobendan
| CAS No | 74150-27-9 |
|---|---|
| Molecular Formula | C19H18N4O2 |
| Molecular Weight | 334.4 g/mol |
| Synonyms | 3-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pimobendan is a veterinary medication mainly used for the management of heart failure in dogs, especially conditions like myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM).
The listed CAS number is 74150-27-9.
The listed molecular formula is C19H18N4O2.
The listed molecular weight is 334.4 g/mol.
3-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one.
The source lists Pimobendane, Acardi and dl-Pimobendan.